The pioneering technology to treat MGD (Meibomian Gland Dysfunction).
E-Eye is since 2015 specially certified to treat MGD, creating a pioneering position on the market.
The working solution to treat dry eye
The results of several independent international E>Eye-studies speak for themselves…
recommend the treatment
confirm improvement of symptoms
stop using eye-drops after the treatment
* Veale J. E-Eye IPL Dry Eye Treatment Customer Satisfaction Results, July 2015.
E-Eye User Survey Results
Thanks to the feedback of over 100 global E-Eye users who took the 2021 Feedback Survey, ESW vision was able to evaluate user profiles, dry eye practice metrics and patient and user experiences.
The problem of dry eyes …
Almost one in five people know the problem: the eyes are stinging, scratchy, reddened, and feel as if filled with sand. This is also known as the dry eye syndrome. Many influences of daily (modern) life strain the eye and cause and trigger later discomfort and eye pain that may often be persistent.
Redness, fatigue, blurred vision and scratchy eyes are the first signs of eye discomfort. Over the time many other symptoms and serious complications can occur, like uncomfortable changings in vision comfort and infections.
Dry eye treatment by E-Eye
It has been proven in several neurological studies that the emission on a nerve of infrared as a train of pulses leads to the creation of a micro gradient of temperature between the inner and the outer layer of the myelin sheath.
This micro gradient of temperature triggers the liberation of neurotransmitters. Automatically, the parasympatic nerve is connected to the Meibomian glands by some of its branches. The neurotransmitters released will then be able to interact with the glands, stimulating the secretion and the contraction of the latter.
E-Eye does not directly affect the Meibomian glands. Its action is indirect. The “flashed” areas (buborbital and zygomatic region) are the areas where the parasympathetic nerve passes.
How it works?
The dry eye treatment with E-Eye only takes a few minutes, sitting in a comfortably chair. The eyes from the patient are covered by protective eyecups. Hydrogel is applied to the lower eyelid. A series of light pulses is performed around the lower eye, gentle and non-invasive. The series is repeated in the same way for both eyes. The treatment restores the normal activity of the Meibomian gland, with very rapid improvement for the patient from the very first session. The effect of first two treatments lasts a few days up to 2 to 3 weeks. The long-lasting effect is expected for minimum 6 months up to 3 years. The E-Eye protocol comprises three to four sessions. It is recommended to repeat one application once symptoms are coming back.
As a result, the dry lipid layer receives a natural boost of lipids, which reduces the evaporation of tear fluid and prevents the eye from drying out. In addition, the quality of the glandular secretions is improved, and the tear film‘s lipid layer is stabilized.
The patented IRPL® technology
E-Eye is a medical device that has been specifically designed for treating dry eye syndrome due to MGD.
It generates Intense Regulated Pulsed Light by producing perfectly calibrated and homogeneously sequenced light pulses. The sculpted pulses are delivered under the shape of a train of pulses. The energy, spectrum and time period are precisely set to stimulate the Meibomian glands in order for them to return their normal function. E-Eye is the medical solution to treat and to prevent dry eyes.
Since the start of international distribution in 2016, E-Eye has set up in many countries. E-Eye is a proven solution now available in more than 50 countries around the world!
E-Eye Key Figures
- Pioneering treatment technology for dry eye due to Meibomian Gland Dysfunction (MGD).
- Until 2020, over 250.000 patients have been treated with the E-Eye!
- 85% patient satisfaction rate, proven efficacy on mild, medium and severe dry eye. 1
- Several clinical studies conducted confirming the efficacy of
E-Eye treatment technology and the improvement of dry eye conditions. 2
- User and patient surveys confirm the high satisfaction with the treatment. 3
- Up to 3 years longterm relief for your patient.
1 Veale J. E-Eye IPL Dry Eye Treatment Customer Satisfaction Results, July 2015.
2 2020 New Zealand – Prof. Dr. Jennifer P. Craig, 2019 Italy – Dr. Luca Vigo, further references see Press/Studies
3 E-Eye User Survey 2021
E-Eye is medical CE-marked and registered in the main global markets: CFDA (China) / TGA (Australia) / Anvisa (Brazil) / Health Canada / FDA* (USA) / …
* In the United States, E>Eye is not currently FDA-cleared for the treatment of Dry Eye Disease (DED) or Meibomian Gland Dysfunction (MGD).
** E>Eye is FDA cleared under 510(k) K200616 for the following indication for use: E>Eye is a prescription device indicated for the treatment of Rosacea.
Dimensions (length x width x height)
Max 345 x 320 x 440 mm
29 x 18 x 24 inches
Max 11 kg (24 pounds)
Max 55 dBA
100 – 240 VAC
Maximum power consumption
Usage temperature / Storage temperature
+5°C – +25°C / -5°C – +65°C
41°F to 77°F / 23°F to 149°F
Authorised humidity (without condensation)
30 – 93 %
E-Eye was designed and developed to treat dry eye in a very efficient way, based on the innovative IRPL® (Intense Regulated Pulsed Light) technology, patent by E-Swin.
Easy & quick to use
It only takes a few minutes to perform an E-Eye IRPL® treatment. The device is ready for use within seconds: it doesn’t require any pre-heating. Self-explaining settings on the touchscreen.
For optimum results, perform treatments on Day 1, Day 15 and Day 45 (optional Day 75 in case of severe dry eye).
1 – Pre-treatment
After a consultation with the patient to review the dry eye condition, the practitioner will assess skin phototype, which is graded from I (very fair skin) to V (dark skin). A consent form is given to the patient before each treatment. It aims to inform and check for any contraindication.
2 – Treatment
The patient is sitting comfortably on a treatment chair, preferably tilted.
After cleaning the skin from any make up, the eyes of the patient will be covered by protective goggles and the practitioner applies conductive gel on the cheekbone and the temporal areas. A series of 5 flashes is applied under the lower eyelid – starting from inner to outer side of the eye. The application is done the same on both eyes.
3 – Post-treatment
E-Eye treatments are non-invasive, simple and safe. Patients generally experience a relief within a few minutes following the session. Make up can be applied again on the skin directly after the treatment. Patient can continue “daily life” right after the treatment.
A dry eye treatment using E-Eye shall not be performed in case of any given contraindications. A consent form including a compatibility check list is assisting to verify any potential risk for the patient.